Concepedia

Athri D. Rathnayake

AD

Statistics

Publications

12

Citations

700

H-Index

11

Active since

2016

Affiliations

Wichita State University(Current)

Kansas State University

University of Kansas

New York Structural Biology Center

University of Iowa

Athri D. Rathnayake is an author at Wichita State University specializing in antiviral pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2016–2022

12

Publications

12

3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice

Athri D. Rathnayake, Jian Zheng, Yunjeong Kim et al. · Science Translational Medicine · 2020 · 295 citations · Full text

, , +17

Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element

Anushka C. Galasiti Kankanamalage, Yunjeong Kim, Vishnu C. Damalanka et al. · European Journal of Medicinal Chemistry · 2018 · 122 citations · Full text

, , +17

Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease

Chamandi S. Dampalla, Yunjeong Kim, Naemi P. Bickmeier et al. · Journal of Medicinal Chemistry · 2021 · 59 citations · Full text

, , +16

Structure-Guided Design of Potent Spirocyclic Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3C-like Protease

Chamandi S. Dampalla, Athri D. Rathnayake, Anushka C. Galasiti Kankanamalage et al. · Journal of Medicinal Chemistry · 2022 · 38 citations · Full text

, , +15

Protease inhibitors broadly effective against feline, ferret and mink coronaviruses

Krishani Dinali Perera, Anushka C. Galasiti Kankanamalage, Athri D. Rathnayake et al. · Antiviral Research · 2018 · 35 citations

, , +14

1–5 of 12